| Dr Gaurav Bandi, MD | |
|
3800 Reservoir Rd Nw, Washington, DC 20007-2113 | |
| (202) 444-4922 | |
| Not Available |
| Full Name | Dr Gaurav Bandi |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 24 Years |
| Location | 3800 Reservoir Rd Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891750196 | NPI | - | NPPES |
| P00752491 | Other | DC | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 49267 (Wisconsin) | Secondary |
| 208800000X | Urology | MD038156 (District Of Columbia) | Primary |
| 208800000X | Urology | MD431151 (Pennsylvania) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Georgetown University Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Chlorthalidone, the guideline-recommended diuretic for lowering blood pressure, causes more serious side effects than hydrochlorothiazide, a similarly effective diuretic, according to a new study led by researchers at Columbia University Irving Medical Center.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.
The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.
A new guide seeks to ensure healthcare providers are ready to help new mothers with the challenging first week of breastfeeding – and to address gaps in knowledge and support created in previous decades when breastfeeding was far less common.
And according to new data, the majority of teens say the greatest risk in using marijuana is upsetting their parents (69%), followed by losing the respect of friends and family (67.2%).
› Verified 2 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000415 |
News Archive
Chlorthalidone, the guideline-recommended diuretic for lowering blood pressure, causes more serious side effects than hydrochlorothiazide, a similarly effective diuretic, according to a new study led by researchers at Columbia University Irving Medical Center.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.
The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.
A new guide seeks to ensure healthcare providers are ready to help new mothers with the challenging first week of breastfeeding – and to address gaps in knowledge and support created in previous decades when breastfeeding was far less common.
And according to new data, the majority of teens say the greatest risk in using marijuana is upsetting their parents (69%), followed by losing the respect of friends and family (67.2%).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gaurav Bandi, MD Po Box 418283, Boston, MA 02241-8283 Ph: (703) 558-1544 | Dr Gaurav Bandi, MD 3800 Reservoir Rd Nw, Washington, DC 20007-2113 Ph: (202) 444-4922 |
News Archive
Chlorthalidone, the guideline-recommended diuretic for lowering blood pressure, causes more serious side effects than hydrochlorothiazide, a similarly effective diuretic, according to a new study led by researchers at Columbia University Irving Medical Center.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.
The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.
A new guide seeks to ensure healthcare providers are ready to help new mothers with the challenging first week of breastfeeding – and to address gaps in knowledge and support created in previous decades when breastfeeding was far less common.
And according to new data, the majority of teens say the greatest risk in using marijuana is upsetting their parents (69%), followed by losing the respect of friends and family (67.2%).
› Verified 2 days ago
Harry Guilford Rushton Jr., MD Urology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-2670 | |
Tanya Dzintra Davis, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 111 Michigan Ave Nw, Children's National Health System, Washington, DC 20010 Phone: 202-476-5000 | |
Salman Chohan, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 1310 Southern Ave Se, Washington, DC 20032 Phone: 202-574-5432 Fax: 202-574-7188 | |
Michael Hsieh, M.D., PH.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5042 | |
Kelly Alison Chiles, MD Urology Medicare: Medicare Enrolled Practice Location: 2150 Pennsylvania Ave Nw, Suite 3-417, Washington, DC 20037 Phone: 202-741-2388 | |
Dr. Dorota Joanna Hawksworth, M.D. Urology Medicare: Medicare Enrolled Practice Location: Walter Reed Army Medical Center Urology, 6900 Georgia Ave, Bldg 2, 4th Fl, Washington, DC 20307 Phone: 202-782-6406 | |
Dr. Keith John Kowalczyk, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Department Of Urology, 4phc, Washington, DC 20007 Phone: 202-444-4922 Fax: 877-625-1478 |